Skip to main content
2025 CNSF Congress Main banner
Final Program


Calendar-of-Events
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Industry Supported Session

Lunch 'n Learn: Targeting FcRn in gMG: Bridging Clinical Trials to Real-World Outcomes

Tuesday, June 10, 2025
12:15 PM – 1:45 PM ET

Audience:

Adult Neurologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Basic (Resident, New Information), Intermediate (Practicing Physician), Advanced (Special Interest, Higher Level Discussion)

Learning Format:

Audience response system, Case studies, Lecture/plenary method, Question and answer sessions, Small group discussion

Looking for targeted therapies for your generalized myasthenia gravis (gMG) patients? Join us for an interactive program that explores the game-changing role of FcRn inhibitors, bridging clinical trial data, the latest real-world evidence, and real Canadian patient cases. Through dynamic discussions and practical scenarios, you’ll learn to apply shared decision-making and goal-setting to optimize gMG care. Engage, apply, and elevate your practice—because your patients deserve the best.

This program was developed by the CNSF and argenx Canada and was planned to achieve scientific integrity, objectivity and balance. It is an unaccredited learning activity and not eligible for MOC credits.

Learning Objectives:

  • Identify the unmet needs in managing generalized myasthenia gravis (gMG) and assess their impact on patient care and quality of life in Canada
  • Evaluate the evolving gMG treatment landscape, with a focus on FcRn clinical trial evidence, global real-world evidence, and Canadian clinical cases
  • Apply shared decision-making and goal-setting strategies when implementing FcRn inhibitors into clinical practice to enhance Canadian patient health outcomes

Presentations:

  • 12:15 PM – 12:20 PM ET
    Introduction & Pre-Test
  • 12:20 PM – 12:30 PM ET
    The gMG Landscape
  • 12:30 PM – 1:00 PM ET
    Evidence-Based Approaches in the Management of gMG
  • 1:00 PM – 1:15 PM ET
    Real-World Patient Case Series
  • 1:15 PM – 1:35 PM ET
    Shared Decision-Making and Goal Setting for Improved Patient Outcomes
  • 1:35 PM – 1:45 PM ET
    Conclusion and Next Steps